Product Pipeline
Find out about the anti-cancer drugs we have in the development
PRESS RELEASES
-
Cullinan Oncology and Taiho Pharmaceutical Announce Strategic Collaboration to Jointly Develop and Commercialize CLN-081/TAS6417 and Taiho’s Acquisition of Cullinan Pearl
-
U.S. Food and Drug Administration (FDA) Accepts for Priority Review Taiho Oncology’s New Drug Application for Futibatinib for Cholangiocarcinoma
-
Taiho Oncology Recognizes the Important Role of Advocacy Organizations in Marking National Colorectal Cancer Awareness Month